Merck Insider Maraldo Balances Shares and Options Ahead of Oncology Boom【Flash】
Merck insider David Maraldo balances cash and equity: buys RSUs, sells shares near $129, and keeps a strong 401(k) stake—signals confidence in the firm’s growth.
3 minutes to read